A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2004
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482950A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
12/08/2004	EP1482942A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482920A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1141014B1 Insulin-like growth factor (igf) i mutant variant
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553890A Crystals of hydroxynorephedrine derivative
12/08/2004	CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1552386A Medicine for treating human lithic disease
12/08/2004	CN1552377A Kidney and liver relieving pills and their preparation
12/08/2004	CN1552368A Fuyankang pills against gynecologic inflammation and their preparation
12/08/2004	CN1552361A Kidney pills and their preparation
12/08/2004	CN1552340A Medicine for preventing nephroma
12/08/2004	CN1552336A Medicine for preventing prostatic disorders
12/08/2004	CN1552330A Paint for treating benign prostate hyperplasia and its use
12/08/2004	CN1552329A Powder injection of cefpiramide
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178656C Pharmaceutical composition
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6827938 Compositions and methods for improving kidney function
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103954A1 Amide derivative
12/02/2004	WO2004103407A2 Composition comprising a pde4 inhibitor and a pde5 inhibitor
12/02/2004	WO2004103387A1 The uses of bamboo leaf total flavones for the preparation of medicaments and health foods for preventing and treating for prostate diseases
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242887 Hypotonic bladder diseases
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242686 Crystals of hydroxynorephedrine derivative
12/02/2004	US20040242682 Compositions comprising arginine and nitrates
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242651 to gastrointestal systems, kidneys
12/02/2004	US20040242647 Use of organic compounds
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242629 Quinuclidine carbamate derivatives and their use as M3 antagonists
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242617 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
12/02/2004	US20040242601 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242575 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc.
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242569 Quatemary ammonium compounds
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242547 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
12/02/2004	US20040242479 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040242455 which exerts potent and selective activated blood coagulation factor X inhibitory activity and is useful for prevention or treatment of disease associated therewith
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241800 Vascular endothelial growth factor dimers
12/02/2004	US20040241226 Administering a tyrosine kinase inhibitor, more particularly a non toxic, potent and selective c-kit inhibitor, wherein said inhibitor is unable to promote death of IL-3 dependent cells cultured to presence of IL-3
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/02/2004	CA2525946A1 Composition comprising a pde4 inhibitor and a pde5 inhibitor
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481964A1 Stable salts of novel derivatives of 3,3-diphenylpropylamines
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1480993A2 Desaturase genes, enzymes encoded thereby, and uses thereof
12/01/2004	EP1480976A1 Thiazole derivatives as npy receptor antagonists
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480736A2 Microcapsules having high carotenoid content
12/01/2004	EP1480647A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
12/01/2004	EP1480634A2 Treating benign prostate hyperplasia with sarms
12/01/2004	EP1480631A2 Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480514A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
12/01/2004	EP1358180B1 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
12/01/2004	EP1263761B1 Compounds for pdt

1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 562